NCI-designated Basic Laboratory Cancer Centers get research done—efficiently

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Having had the honor and pleasure to lead an NCI-designated cancer center for several years, I would like to share my thoughts on this small yet unique set of institutes and their value to NCI and the nation. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Ze’ev Ronai, PhD
Director, Translational Research Institute, Professor, Department of Biomedical Sciences and the Jim and Eleanor Randall Department of Surgery, Scientific director, Surgical Melanoma Research Program, Randall Department of Surgery, Cedars Sinai Medical Center
Table of Contents

YOU MAY BE INTERESTED IN

Ivan Borrello, medical director of the Myeloma, Bone Marrow Transplant and Cell Therapies Program at Tampa General Hospital’s Cancer Institute, watched as flood waters from Hurricane Helene heaved against a contraption called the AquaFence, which is, as the name suggests, a water-impermeable barrier made of marine-grade laminate and various metals that can withstand storm surges of up to 15 feet above sea level. 
Ze’ev Ronai, PhD
Director, Translational Research Institute, Professor, Department of Biomedical Sciences and the Jim and Eleanor Randall Department of Surgery, Scientific director, Surgical Melanoma Research Program, Randall Department of Surgery, Cedars Sinai Medical Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login